ArticleJournal of the American Heart Association2022

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis.

Mitsuru Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.